Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
ETVAX
BIOLOGICAL
3 trials
Sponsors
PATH
, Scandinavian Biopharma AB
, Scandinavian Biopharma Holding AB
Conditions
Digestive System
Escherichia Coli Diarrhea
Healty Volunteers
Preventable Disease, Vaccine
Phase 1
Enterotoxigenic Escherichia Coli (ETEC) ETVAX Vaccine Trial in Bangladesh
Completed
NCT02531802
PATH
Escherichia Coli Diarrhea
Start: 2015-10-31
End: 2017-07-29
Updated: 2018-09-12
Phase 2
OEV128 Gambia ETVAX Efficacy Trial (GEET)
Active, not recruiting
PACTR202010819218562
Scandinavian Biopharma Holding AB
Digestive System
Start: 2021-01-11
Target: 4936
Updated: 2026-01-27
A Phase 2 Bridging Study to Assess the New Formulation of ETVAX
Completed
NCT05178134
Scandinavian Biopharma AB
Healty Volunteers, Preventable Disease, Vaccine
Start: 2021-11-08
End: 2022-10-20
Updated: 2025-08-19
Related Papers
Safety and immunogenicity of the oral, inactivated, enterotoxigenic Escherichia coli vaccine ETVAX in Bangladeshi children and infants: a double-blind, randomised, placebo-controlled phase 1/2 trial.
2019-11-19
84 citations
Evaluation of the safety and immunogenicity of the oral inactivated multivalent enterotoxigenic Escherichia coli vaccine ETVAX in Bangladeshi adults in a double-blind, randomized, placebo-controlled Phase I trial using electrochemiluminescence and ELISA assays for immunogenicity analyses
Vaccine
2018-11-22
61 citations